Abstract: The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.

Abstract: Systems and methods for optimizing network traffic are disclosed. In one embodiment, a system for optimizing the performance of a plurality of networks includes a first terminal device, a traffic steering controller, and a terminal traffic steering agent. The traffic steering controller may be configured to receive user profiles and network performance metrics and create traffic steering rules based on the user profiles and network metrics. The terminal traffic steering agent may be configured to receive traffic steering rules from the traffic steering controller and direct a virtual network switch based on the traffic steering rules. The virtual network switch may be configured to receive network traffic at a virtual network interface and, based on directions received from the traffic steering controller, forward the network traffic to a physical interface of at least one of the plurality of networks.

Abstract: The technology described in this document can be embodied in a computer-implemented method that includes receiving, at a processing system, a first signal including an output of a speaker device and an additional audio signal. The method also includes determining, by the processing system, based at least in part on a model trained to identify the output of the speaker device, that the additional audio signal corresponds to an utterance of a user. The method further includes initiating a reduction in an audio output level of the speaker device based on determining that the additional audio signal corresponds to the utterance of the user.

Abstract: Systems and methods automatically locate optical surfaces of an eye and automatically generate surface models of the optical surfaces. A method includes OCT scanning of an eye. Returning portions of a sample beam are processed to locate a point on the optical surface and first locations on the optical surface within a first radial distance of the point. A first surface model of the optical surface is generated based on the location of the point and the first locations. Returning portions of the sample beam are processed so as to detect second locations on the optical surface beyond the first radial distance and within a second radial distance from the point. A second surface model of the optical surface is generated based on the location of the point on the optical surface and the first and second locations on the optical surface.

Abstract: A method of imaging an object includes obtaining an image data set from a raster scan. The image data set has a plurality of data points, each data point having an associated location and intensity; generating a reduced data set by selectively removing one or more data points from the image data set based upon an assigned probability of retaining the one or more data points in the data set, the assigned probability being a function of the intensity of a data point; generating a triangulation graph as a planar subdivision having faces that are triangles, the vertices of which are the data points and the edges of which are adjacent vertices; and segmenting the triangulated data set by finding a path with lowest cost between that vertex and every other vertex, wherein the cost is a function of the respective intensity of the vertices.

Abstract: The present invention describes peptides comprising phycocyanobilin (PCB), as well as the medical use of said peptides and that of PCB, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of PCB with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative CNS disease treatment.

Abstract: A power control unit 16 controls the power consumed by a system 10 having a plurality of electrical power consumption states including an active state and at least one power saving state. The system comprises a plurality of subsystems 12 each having a plurality of subsystem power states including an active state and at least one power saving state. The electrical power consumption states of the system correspond to respective different configurations of subsystem power states of the subsystems and the power control unit is arranged for signal interface with the subsystems and a power supply unit 14 of the system for controlling the subsystem power states of each of the subsystems and the power supplied to each of the subsystems by the power supply unit dependent on the required power consumption state of the system.

Abstract: The technology described in this document can be embodied in a computer-implemented method that includes receiving, at a processing system, a first signal including an output of a speaker device and an additional audio signal. The method also includes determining, by the processing system, based at least in part on a model trained to identify the output of the speaker device, that the additional audio signal corresponds to an utterance of a user. The method further includes initiating a reduction in an audio output level of the speaker device based on determining that the additional audio signal corresponds to the utterance of the user.

Abstract: The present invention relates to nanoparticles for the encapsulation of compounds, the obtaining and uses thereof. The nanoparticles comprise a zein matrix and a basic amino acid. The nanoparticles can encapsulate a water-soluble or fat-soluble biologically active compound. It is applicable in the food, pharmaceutical and cosmetic sectors and in the nanotechnology sector.

Abstract: The technology described in this document can be embodied in a computer-implemented method that includes receiving, at a processing system, a first signal including an output of a speaker device and an additional audio signal. The method also includes determining, by the processing system, based at least in part on a model trained to identify the output of the speaker device, that the additional audio signal corresponds to an utterance of a user. The method further includes initiating a reduction in an audio output level of the speaker device based on determining that the additional audio signal corresponds to the utterance of the user.

Abstract: A printhead control system comprises a voltage supply control module to selectively supply an operating voltage to a printhead, and the voltage supply control module is configured to receive a first and a second control voltages, and to disconnect the supply of operating voltage to the printhead at least when the first and second control voltages have the same logical level.

Abstract: A method includes collecting interface information on a plurality of services. The services include core infrastructure and translation services. The method also includes correlating the interface information to provide subscriber and IP addressing information, and provisioning the subscriber and IP addressing information to different services based on a rule provisioning policy.

Abstract: This invention is related to a pharmaceutical combination that contains a Casein kinase 2 (CK2) peptide inhibitor (termed P15) along with the standard chemotherapeutic drugs used in cancer treatment and which are administered together, separated or sequentially. The chemotherapeutic drugs include cisplatin, taxol, alkaloids from Vinca, 5-fluorouracil, doxorubicin, cyclophosphamide, etoposide, mitomycin C, imatinib, iressa, velcade (bortezomib), cytarabine (Ara C), fludarabine and mitroxantrone. The synergism between the P15 peptide and the anticancer drugs achieves an efficient concentration of each cytostatic drug in the combination which is from 10- to 100-fold lower than that for each cytostatic drug alone. The pharmaceutical combination described in this invention exhibits lower toxicity compared to that reported by the anticancer therapeutics and therefore, it represents a crucial advantage for its use in cancer therapy.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for identifying the language of a spoken utterance. One of the methods includes receiving a plurality of audio frames that collectively represent at least a portion of a spoken utterance; processing the plurality of audio frames using a long short term memory (LSTM) neural network to generate a respective language score for each of a plurality of languages, wherein the respective language score for each of the plurality of languages represents a likelihood that the spoken utterance was spoken in the language; and classifying the spoken utterance as being spoken in one of the plurality of languages using the language scores.

Abstract: This invention is related to a pharmaceutical combination that contains a Casein kinase 2 (CK2) peptide inhibitor (termed P15) along with the standard chemotherapeutic drugs used in cancer treatment and which are administered together, separated or sequentially. The chemothearapeutic drugs include cisplatin, taxol, alkaloids from Vinca, 5-fluorouracil, doxorubicin, cyclophosphamide, etoposide, mitomycin C, imatinib, iressa and velcade (bortezomib). The synergism between the P15 peptide and the anticancer drugs achieves an efficient concentration of each cytostatic drug in the combination which is from 10- to 100-fold lower than that for each cytostatic drug alone. The pharmaceutical combination described in this invention exhibits lower toxicity compared to that reported by the anticancer therapeutics and therefore, it represents a crucial advantage for its use in cancer therapy.

Abstract: The subject invention provides a flight simulator, having a folded state and an unfolded state, having a chassis, an inner display and support that may be stowed or deployed, and an outer display and support that may be stowed or deployed.

Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for language identification. In some implementations, speech data for an utterance is received and provided to (i) a language identification module and (ii) multiple speech recognizers that are each configured to recognize speech in a different language. From the language identification module, language identification scores corresponding to different languages are received, the language identification scores each indicating a likelihood that the utterance is speech in the corresponding language. A language model confidence score that indicates a level of confidence that a language model has in a transcription of the utterance in a language corresponding to the language model is received. A language is selected based on the language identification scores and the language model confidence scores.

Abstract: A position encoder signal control system is disclosed. A position encoder input line receives a position encoder signal and a diagnostic input line receives a position encoder diagnostic signal. An output line is couplable to a position encoder output channel and a controller selectively connects one of the position encoder input line and the diagnostic input line to the output line.

Abstract: The invention relates to microparticles comprising a matrix formed by casein and chitosan, and probiotic bacteria; said matrix protects said probiotic bacteria during (i) processing, (ii) storage and (iii) transit through the gastrointestinal tract, prolonging their lifetime. The present invention also relates to the method for obtaining the microparticles and to the products and compositions incorporating them.

Abstract: A printing apparatus comprises a print zone and a media handling system for advancing media through a media path and through the print zone, wherein the media handling system comprises a first media driving arrangement positioned downstream of the print zone in the direction of advance of the media, and a second media driving arrangement positioned downstream of the first arrangement, the second media driving arrangement being operable to cause the tension of the media in a deformation zone between the two driving arrangements to be lower than the tension of the media in the print zone.